96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B.

scientific article

96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JHEP.2007.10.013
P698PubMed publication ID18207280
P5875ResearchGate publication ID5644931

P50authorYuen Kwok-yungQ8060280
John M. LukQ42935545
Chee-Kin HuiQ125201039
P2093author name stringApril Wong
George K K Lau
Hai-Ying Zhang
Stephen Locarnini
Scott Bowden
Yui-Hung Yueng
Kar-Wai Leung
Frank Rousseau
Nikolai N Naoumov
P433issue5
P921main subjectemtricitabineQ422604
chronic hepatitisQ62019625
P304page(s)714-720
P577publication date2007-12-31
P1433published inJournal of HepatologyQ15724402
P1476title96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B
P478volume48